256 Newsroom — Uganda's Digital News Infrastructure
Business

Is Ultragenyx Stock a Buy After GTX-102 Flop? Analysts Point to Commercial Pipeline - Barron's

Published by Barron's By Mackenzie Tatananni · 3 September 2026 at 19:28
Share
Is Ultragenyx Stock a Buy After GTX-102 Flop? Analysts Point to Commercial Pipeline - Barron's
Image · Barron's

What the report says

Ultragenyx Pharmaceuticals looks to cut costs following the trial failure, while attention remains squared on its burgeoning commercial business.

Read the full report at Barron's →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

256 Newsroom Nigeria Urges Uganda to Sign SAATM to Boost Air Connectivity, Trade - ChimpReportsChimpReports 256 Newsroom Uganda Targets Nigeria’s Pharmaceutical Market as Trade Ties Deepen - ChimpReportsChimpReports 256 Newsroom South African banks turn to East Africa in search of growth - Daily MonitorDaily Monitor 256 Newsroom URA turns to govt databases to hunt for missing taxpayers - Daily MonitorDaily Monitor Two ‘Dancing Generals’ arrested as intelligence probe widensThe Independent Uganda 256 Newsroom Korea International Trade Association Archives - PML DailyPML Daily